Capstone Asset Management’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$421K Buy
16,041
+150
+0.9% +$3.69K 0.01% 1015
2017
Q1
$372K Sell
15,891
-770
-5% -$19K 0.01% 1111
2016
Q4
$419K Buy
16,661
+4,650
+39% +$117K 0.01% 1066
2016
Q3
$337K Sell
12,011
-310
-3% -$7.95K 0.01% 1238
2016
Q2
$304K Buy
12,321
+110
+0.9% +$2.73K 0.01% 1285
2016
Q1
$270K Sell
12,211
-490
-4% -$13K 0.01% 1337
2015
Q4
$445K Sell
12,701
-5,810
-31% -$182K 0.01% 998
2015
Q3
$527K Buy
18,511
+1,150
+7% +$38.6K 0.02% 886
2015
Q2
$578K Sell
17,361
-1,790
-9% -$55K 0.02% 872
2015
Q1
$540K Buy
19,151
+570
+3% +$14.2K 0.02% 1031
2014
Q4
$385K Sell
18,581
-1,730
-9% -$41.1K 0.01% 1225
2014
Q3
$496K Buy
20,311
+240
+1% +$6.36K 0.02% 1029
2014
Q2
$574K Buy
20,071
+2,042
+11% +$56.8K 0.02% 958
2014
Q1
$504K Sell
18,029
-1,050
-6% -$25.8K 0.02% 1068
2013
Q4
$410K Sell
19,079
-3,479
-15% -$63.2K 0.01% 1295
2013
Q3
$299K Buy
22,558
+48
+0.2% +$647 0.01% 1671
2013
Q2
$312K Buy
+22,510
New +$319K 0.01% 1553

Other funds holding PMC

Capstone Asset Management's PMC Position: Q2 2017 in Review

Capstone Asset Management increased its PharMerica Corporation (PMC) stake by 0.94% in Q2 2017, buying an estimated $3.69K and bringing the position to 16,041 shares worth $421K. The position accounts for 0.01% of the portfolio, ranked #1015.

Capstone Asset Management first reported a position in PMC in Q2 2013 and has held it in 17 quarters since. The position peaked at $578K in Q2 2015. 157 funds tracked by Wall St. Rank hold PMC as of Q2 2017.

  • Capstone Asset Management held 16,041 shares of PharMerica Corporation worth $421K as of Q2 2017.
  • Capstone Asset Management bought 150 PharMerica Corporation shares in Q2 2017, an estimated $3.69K.
  • PharMerica Corporation made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1015 holding.
  • Capstone Asset Management first reported a position in PharMerica Corporation in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's PharMerica Corporation position peaked at $578K in Q2 2015.
  • 157 funds tracked by Wall St. Rank held PharMerica Corporation as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.